• DocumentCode
    3298964
  • Title

    Glycation induced modification and identification of AGEs-precursors and AGEs in human serum albumin

  • Author

    Ahmad, Waqar ; Deng, Yulin ; Ahmad, Manzoor ; Iqbal, Zafar

  • Author_Institution
    Dept. of Pharmacy, Univ. of Malakand, Chakdara
  • fYear
    2009
  • fDate
    9-11 April 2009
  • Firstpage
    1
  • Lastpage
    6
  • Abstract
    AGEs are a heterogeneous group of proteins that have been shown to react with the amino group of the N-terminal amino acid residue and the side-chains of arginine and lysine residues. Glycation induced protein modifications has been implicated in diabetes and its associated complications like nephropathy, retinopathy, aging as well as in atherosclerosis, Alzheimer´s and Parkinson´s diseases. The identification and structure elucidation of AGEs is therefore of great importance. Mass spectrometry, due to its high specificity and sensitivity, has widely been applied for the identification and structure elucidation of AGEs. We report the identification of AGEs-precursors and AGEs based on relative mass changes due to specific AGEs formation. HPLC-ESIMS, ESI-MS/MS and mascot data base were used to identify peptides sequence for non-glycated HSA. The relative mass changes due to specific AGE-precursors and AGEs formation were added to the non-glycated peptides followed by a thorough manual search of the glycated samples that resulted in the identification of ten modified peptides for the formation of five AGEs namely CML (1), Pyrraline (3), Imidazolone A (2), Imidazolone B (1) and AFGP (3). Also, seven glycated peptides were identified for the formation of AGEs-precursors.
  • Keywords
    biochemistry; mass spectroscopic chemical analysis; proteins; proteomics; AFGP AGE protein; AGE precursor identification; AGE precursor modification; AGE structure elucidation; Alzheimers disease; CML AGE protein; ESI-MSMS; HPLC-ESIMS; N terminal amino acid residue amino group; Parkinsons disease; advanced glycation end product; arginine residue side chain; atherosclerosis; diabetes; electrospray ionization mass spectrometry; glycated peptides; glycation induced protein modification; human serum albumin AGE; imidazolone A AGE protein; imidazolone B AGE protein; lysine residue side chain; mass spectrometry; nephropathy; nonglycated HSA peptide sequence identification; pyrraline AGE protein; retinopathy; Aging; Amino acids; Atherosclerosis; Diabetes; Humans; Mass spectroscopy; Parkinson´s disease; Peptides; Proteins; Retinopathy;
  • fLanguage
    English
  • Publisher
    ieee
  • Conference_Titel
    Complex Medical Engineering, 2009. CME. ICME International Conference on
  • Conference_Location
    Tempe, AZ
  • Print_ISBN
    978-1-4244-3315-5
  • Electronic_ISBN
    978-1-4244-3316-2
  • Type

    conf

  • DOI
    10.1109/ICCME.2009.4906680
  • Filename
    4906680